Page last updated: 2024-11-06

cv 6504

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CV 6504: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93543
SCHEMBL ID2715544
MeSH IDM0185014

Synonyms (14)

Synonym
cv-6504
2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone
117574-40-0
cv 6504
2,3,5-trimethyl-6-(pyridin-3-ylmethyl)cyclohexa-2,5-diene-1,4-dione
2,5-cyclohexadiene-1,4-dione,2,3,5-trimethyl-6-(3-pyridinylmethyl)-
2,5-cyclohexadiene-1,4-dione, 2,3,5-trimethyl-6-(3-pyridinylmethyl)-
SCHEMBL2715544
DTXSID80151827
IPGAFOVEIIWXFR-UHFFFAOYSA-N
6-(3-pyridylmethyl)-2,3,5-trimethyl-1,4-benzoquinone
EX-A2681
cv6504;cv 6504
BCP29522
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)0.06200.00462.018210.0000AID166529
Thromboxane-A synthase Homo sapiens (human)IC50 (µMol)0.40000.00091.230410.0000AID212454
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processThromboxane-A synthase Homo sapiens (human)
icosanoid metabolic processThromboxane-A synthase Homo sapiens (human)
cyclooxygenase pathwayThromboxane-A synthase Homo sapiens (human)
intracellular chloride ion homeostasisThromboxane-A synthase Homo sapiens (human)
response to ethanolThromboxane-A synthase Homo sapiens (human)
positive regulation of vasoconstrictionThromboxane-A synthase Homo sapiens (human)
response to fatty acidThromboxane-A synthase Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
monooxygenase activityThromboxane-A synthase Homo sapiens (human)
thromboxane-A synthase activityThromboxane-A synthase Homo sapiens (human)
iron ion bindingThromboxane-A synthase Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygenThromboxane-A synthase Homo sapiens (human)
heme bindingThromboxane-A synthase Homo sapiens (human)
12-hydroxyheptadecatrienoic acid synthase activityThromboxane-A synthase Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityThromboxane-A synthase Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulumThromboxane-A synthase Homo sapiens (human)
endoplasmic reticulum membraneThromboxane-A synthase Homo sapiens (human)
cytosolThromboxane-A synthase Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID102379Inhibitory activity against MAC16 cell lines2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID2926Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM)2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID23459Partition coefficient (logP)1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID190981Protective effect was evaluated by measuring the urinary total protein by peroral administering 10 mg/kg per day for four weeks in 8 rats1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID166409The compound was tested for inhibitory activity against 5-HETE synthesis in rat RBL-11992Journal of medicinal chemistry, Jul-10, Volume: 35, Issue:14
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
AID102244Inhibitory activity against MAC13 cell lines2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID166529The concentration required to reduce by 50% the amount of LTB4 formed by RBL-1 cells1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID102376Effect on metabolism of arachidonic acid for 5-HETE production through 12-LOX (12-lipoxygenase) pathway2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID102378Effect on metabolism of arachidonic acid for 5-HETE production through 5-LOX (5-lipoxygenase) pathway2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID180669Reduction of lipid peroxide formed in rat brain homogenates.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID212454Inhibition of horse thromboxane A2 synthase evaluated as molar concentration required to reduce thromboxane B2 formed after incubating PGH-2 with platelet microsomes.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID172457Protective effect was evaluated by measuring the urinary albumin by peroral administering 10 mg/kg per day for four weeks in 8 rats1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID182007In vivo percent inhibition of lipid peroxidation in rat brain homogenates at 10e-6 M1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID212601Inhibitory activity against horse thromboxane A2 synthase1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
AID102377Effect on metabolism of arachidonic acid for 5-HETE production through 15-LOX (15-lipoxygenase) pathway2003Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
Effect of catechol derivatives on cell growth and lipoxygenase activity.
AID212775Inhibition of rat thromboxane A2 synthase evaluated as percent inhibition of thromboxane B2 formation after 24 hr of administration at 10 mg/kg.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (72.73)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.62 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]